The Drug Supply Chain: Ripe for a Radical Overhaul

PricewaterhouseCoopers’ latest Pharma 2020 report calls for a “radical overhaul” of the pharmaceutical supply chain.

Yet most manufacturers are still figuring how to “walk before they can run,” says PwC’s Wynn Bailey, one of the report’s authors. We talk with him about the fading of the blockbuster-era supply chain, and how the future supply chain will be an open, two-way street between manufacturer and partners. “The flow of information will become as important as the flow of product,” he says. (Click here to access PwC's "Supplying the Future" report.)